PanGenomic Health, Inc. Class A stock analysis
Want to see TSE:NARA full AI Analyst Report?
PanGenomic Health, Inc. Class A (NARA) Stock Price & Analysis
NARA Stock Chart & Stats
- Day’s Range
- CAD 0.25 - CAD 0.30
- 52-Week Range
- CAD 0.16 - CAD 1.00
- Previous Close
- CAD 0.30
- Volume
- N/A
- Average Volume (3M)
- 617
- Market Cap
- CAD 4.21M
- Enterprise Value
- CAD 10.18M
- Total Cash (Recent Filing)
- CAD 7,717
- Total Debt (Recent Filing)
- CAD 715.34K
- Price to Earnings (P/E)
- ―
- Beta
- -0.00
- Next Earnings
- Nov 26, 2026 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Moderate Absolute Debt
Debt remains moderate in absolute dollar terms and has not been consistently high across every year. This provides some balance-sheet support relative to a more heavily indebted structure, although negative equity still limits financial flexibility and makes external funding important.
Cash Flow Tracks Reported Losses
Free cash flow broadly tracking net income suggests reported losses are not being heavily obscured by non-cash accounting items. That alignment improves transparency around the company’s cash economics, even though the underlying cash outflows remain substantial and persistent.
Losses Reflect Operating Investment
Losses appear connected to operating investment rather than unstable revenue movements, which may indicate spending to develop the business rather than sharp sales volatility. The potential benefit is a clearer path to operating leverage if those investments eventually produce commercial activity.
Bears Say
Pre-revenue Business
The absence of reported revenue means the business has not yet demonstrated commercial traction or a functioning sales engine. Consistently negative gross profit further indicates that the core offering is not currently covering direct costs, leaving future viability dependent on achieving meaningful sales.
Widening Net Losses
Net losses have widened materially into the TTM period, showing that operating costs are increasing faster than the company’s ability to generate earnings. Persistent deterioration raises the amount of capital required to reach profitability and reduces confidence in near-term earnings self-sufficiency.
Persistent Cash Burn
Ongoing negative operating and free cash flow shows that the company is not self-funding its operations. Continued cash burn can consume financial resources, increase reliance on external financing, and make it harder to sustain development or absorb delays in achieving revenue.
PanGenomic Health, Inc. Class A News
PanGenomic Health Launches $2 Million Private Placement to Bolster Working Capital and Reduce Debt
PanGenomic Health, Inc. Class A ( ($TSE:NARA) ) has provided an announcement. PanGenomic Health Inc. has announced a non-brokered private placement of up to 4,000,000 units at $0.50 per unit,
PanGenomic Health to Showcase Agenta Health at Vivacity Conference and Completes Warrant Financing
PanGenomic Health, Inc. Class A ( ($TSE:NARA) ) has issued an update. PanGenomic Health Inc. will present its Agenta Health e-Commerce platform at the Vivacity Wellness Conference in Vancouver, showcasing
PanGenomic Health Unveils AI Platform and Accelerates Warrant Expiration
PanGenomic Health, Inc. Class A ( ($TSE:NARA) ) has provided an announcement. PanGenomic Health has announced the development of NaraCare.AI, a new AI-driven platform designed to provide personalized recommendations for
NARA FAQ
What was PanGenomic Health, Inc. Class A’s price range in the past 12 months?
What is PanGenomic Health, Inc. Class A’s market cap?
When is PanGenomic Health, Inc. Class A’s upcoming earnings report date?
How were PanGenomic Health, Inc. Class A’s earnings last quarter?
Is PanGenomic Health, Inc. Class A overvalued?
Does PanGenomic Health, Inc. Class A pay dividends?
What is PanGenomic Health, Inc. Class A’s EPS estimate?
How many shares outstanding does PanGenomic Health, Inc. Class A have?
What happened to PanGenomic Health, Inc. Class A’s price movement after its last earnings report?
Which hedge fund is a major shareholder of PanGenomic Health, Inc. Class A?
What is the TipRanks Smart Score and how is it calculated?
Company Description
PanGenomic Health, Inc. Class A
Pangenomic Health Inc. is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments to support mental health. The company's mobile app, the Nara App, provides consumers with a knowledge base tailored to an individual's unique user profile. Its PlantGx Platform provides health practitioners with access to a consumer's Nara App data to assist them in optimizing the identification of appropriate natural remedies and monitoring a patient's prognosis.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Maryam Marissen
- Employees
- 0
- Website
- pangenomic.com
- Address
- 200 – 1575 W. Georgia St., Vancouver, BC, V6G 2V3, CA
PanGenomic Health, Inc. Class A (NARA) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 12 | 2 | 7 |
| Technical Analysis | 3 | 2 | 4 |
| Moving Averages | 9 | 0 | 3 |








